(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a ...

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer compared to traditional drug-eluting stent with durable polymer San Francisco, CA --A clinical trial has ...

CALGARY, Alberta--(BUSINESS WIRE)--Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an oversubscribed $27 ...

WASHINGTON - A novel study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) presented a safety advantage without compromising efficacy compared to durable ...

To address concerns of late and very late stent thrombosis associated with first generation drug-eluting stent technology, novel approaches are being tested including stents with bioabsorbable ...

Please provide your email address to receive an email when new articles are posted on . Biotronik announced that a drug-eluting stent system for the treatment of patients with CAD has been approved by ...

The Absorv™ bioabsorbable products from Zeus can safely exist in the human body for controlled periods of time before they are absorbed without causing any harm or negative interactions. Such products ...

When speaking about the future of stents, bioabsorbable polymers and sometimes bioabsorbable magnesium tend to come up--rarely does the conversation turn to ceramics, however. But don't count them out ...

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a ...

Patients with more complex anatomy showed improved clinical outcomes with Biomatrix Flex including less cardiac death (HR: 0.43; 95% CI: 0.21–0.89; p = 0.02). In addition, low rates of definite stent ...